UDITAS

Serial Number 97515642
Registration 7706997
700

Registration Progress

Application Filed
Jul 22, 2022
Under Examination
Oct 17, 2023
Approved for Publication
Aug 22, 2023
Published for Opposition
Aug 22, 2023
Registered
Feb 25, 2025

Trademark Image

UDITAS

Basic Information

Serial Number
97515642
Registration Number
7706997
Filing Date
July 22, 2022
Registration Date
February 25, 2025
Published for Opposition
August 22, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 25, 2025
Registration
Registered
Classes
042

Rights Holder

Editas Medicine, Inc.

03
Address
11 Hurley Street
Cambridge, MA 02141

Ownership History

Editas Medicine, Inc.

Original Applicant
03
Cambridge, MA

Editas Medicine, Inc.

Owner at Publication
03
Cambridge, MA

Editas Medicine, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
1872 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250225)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Feb 25, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 25, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 5, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 5, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 4, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 17, 2024 IUAF S USE AMENDMENT FILED Loading...
Jan 4, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 17, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 8, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 8, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 22, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 22, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 14, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 13, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 13, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 13, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 13, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 22, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 21, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 21, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 15, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 15, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 15, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 27, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical laboratory services; Scientific laboratory services; Pharmaceutical research; Medical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
First Use Anywhere: Oct 10, 2024
First Use in Commerce: Oct 10, 2024

Classification

International Classes
042